144 related articles for article (PubMed ID: 9152521)
1. Changes in biomarker expression in the development of prostatic adenocarcinoma.
Myers RB; Grizzle WE
Biotech Histochem; 1997 Mar; 72(2):86-95. PubMed ID: 9152521
[TBL] [Abstract][Full Text] [Related]
2. Biomarker expression in prostatic intraepithelial neoplasia.
Myers RB; Grizzle WE
Eur Urol; 1996; 30(2):153-66. PubMed ID: 8875196
[TBL] [Abstract][Full Text] [Related]
3. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
[TBL] [Abstract][Full Text] [Related]
4. Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Poczatek RB; Myers RB; Manne U; Oelschlager DK; Weiss HL; Bostwick DG; Grizzle WE
J Urol; 1999 Oct; 162(4):1462-6. PubMed ID: 10492238
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
[TBL] [Abstract][Full Text] [Related]
8. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat.
Xie W; Wong YC; Tsao SW
Prostate; 2000 Jun; 44(1):31-9. PubMed ID: 10861755
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG; Qian J; Maihle NJ
Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
[TBL] [Abstract][Full Text] [Related]
10. Expression of nm23-H1 in prostatic intraepithelial neoplasia and adenocarcinoma.
Myers RB; Srivastava S; Oelschlager DK; Brown D; Grizzle WE
Hum Pathol; 1996 Oct; 27(10):1021-4. PubMed ID: 8892585
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
12. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates.
Kwong J; Lui K; Chan PS; Ho SM; Wong YC; Xuan JW; Chan FL
Prostate; 2003 Jul; 56(2):81-97. PubMed ID: 12746832
[TBL] [Abstract][Full Text] [Related]
13. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
14. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
15. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of prostatic intraepithelial neoplasia.
Bostwick DG; Pacelli A; Lopez-Beltran A
Prostate; 1996 Aug; 29(2):117-34. PubMed ID: 8700801
[TBL] [Abstract][Full Text] [Related]
18. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.
Tennant MK; Thrasher JB; Twomey PA; Birnbaum RS; Plymate SR
J Clin Endocrinol Metab; 1996 Jan; 81(1):411-20. PubMed ID: 8550786
[TBL] [Abstract][Full Text] [Related]
20. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]